Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Jackson

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
British Medical Journal (Clinical Research Ed.)|April 5, 1986
Effects of indomethacin and sulindac on blood pressure of hypertensive patientsR V Lewis, J M Toner, P R Jackson, et al.
QJM : Monthly Journal of the Association of Physicians|January 11, 2000
Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methodsI U Haq, L E Ramsay, P R Jackson, et al.
BMJ (Clinical Research Ed.)|August 19, 2000
Comparison of methods of estimating coronary risk. Authors did not use latest version of Sheffield tableE J Wallis, L E Ramsay, J I Yikona, et al.
BMJ (Clinical Research Ed.)|February 24, 2001
Aspirin for primary prevention. Treatment policy should be based on all trial evidence, not subgroup analysisL E Ramsay, P S Sanmuganathan, E J Wallis, et al.
BMJ (Clinical Research Ed.)|July 22, 1995
Interventions in OXCHECK study waste resourcesI U Haq, P R Jackson, W W Yeo, et al.
Journal of Human Hypertension|June 1, 1995
Should cholesterol be measured in all hypertensives?I U Haq, W W Yeo, P R Jackson, et al.
British Journal of Clinical Practice. Supplement|April 1, 1986
Amiodarone pharmacokineticsD W Holt, G T Tucker, P R Jackson, et al.
Postgraduate Medical Journal|December 1, 1994
Acute renal failure with ACE inhibition in aortic coarctationP A Woodmansey, W W Yeo, P R Jackson, et al.
Journal of Human Hypertension|August 1, 1995
Might non-pharmacological treatment disadvantage patients with hypertension?L E Ramsay, I U Haq, W W Yeo, et al.
Lancet (London, England)|January 18, 1997
Cholesterol and prevention of coronary heart diseaseI U Haq, P R Jackson, W W Yeo, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
British Medical Journal (Clinical Research Ed.)|April 5, 1986
Effects of indomethacin and sulindac on blood pressure of hypertensive patientsR V Lewis, J M Toner, P R Jackson, et al.
QJM : Monthly Journal of the Association of Physicians|January 11, 2000
Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methodsI U Haq, L E Ramsay, P R Jackson, et al.
BMJ (Clinical Research Ed.)|August 19, 2000
Comparison of methods of estimating coronary risk. Authors did not use latest version of Sheffield tableE J Wallis, L E Ramsay, J I Yikona, et al.
BMJ (Clinical Research Ed.)|February 24, 2001
Aspirin for primary prevention. Treatment policy should be based on all trial evidence, not subgroup analysisL E Ramsay, P S Sanmuganathan, E J Wallis, et al.
BMJ (Clinical Research Ed.)|July 22, 1995
Interventions in OXCHECK study waste resourcesI U Haq, P R Jackson, W W Yeo, et al.
Journal of Human Hypertension|June 1, 1995
Should cholesterol be measured in all hypertensives?I U Haq, W W Yeo, P R Jackson, et al.
British Journal of Clinical Practice. Supplement|April 1, 1986
Amiodarone pharmacokineticsD W Holt, G T Tucker, P R Jackson, et al.
Postgraduate Medical Journal|December 1, 1994
Acute renal failure with ACE inhibition in aortic coarctationP A Woodmansey, W W Yeo, P R Jackson, et al.
Journal of Human Hypertension|August 1, 1995
Might non-pharmacological treatment disadvantage patients with hypertension?L E Ramsay, I U Haq, W W Yeo, et al.
Lancet (London, England)|January 18, 1997
Cholesterol and prevention of coronary heart diseaseI U Haq, P R Jackson, W W Yeo, et al.
Pageof 14